Kupffer cell M2-like polarization increases liver metastatic burden via uptake of exosomal KRAS mutant protein from hypoxic colorectal carcinoma cells

Abstract

Backgrounds: This study is to investigate the metastasis promoting effect of colorectal carcinoma cells-derived exosomes in liver metastasis, M2-like polarization of Kupffer cells and the mechanism underlying. Methods: Mouse liver metastasis models were established to testify the involvement of CRC-derived exosomes on liver metastasis, DIR and PKH26 fluorescent labeling strategy were utilized to trace the distribution of CRC-derived exosomes in vivo. GO and KEGG analysis of differential expressed genes revealed the key cellular regulator and KRAS-induced signaling in CRC liver metastasis. Phenotype of Kupffer cells were determined by IHC and IF. Vitro model HMDMs were used to explore polarization phenotype and therapeutic effects of GSK690693 (AKT inhibitor) inhibited AKT. Results: Exosomal mutant KRAS induced AKT signaling in the process of Kupffer cells M2-like polarization, promoting the CRC liver metastasis. AKT inhibitors might potentially be used as a therapeutic approach to prevent liver metastases in CRC. Conclusion: Our findings reveal that exosomal mutant KRAS drives Kupffer cell M2-like polarization via hyperactivation of AKT signaling, establishing this axis as a key mediator of colorectal cancer liver metastasis. Pharmacological inhibition of AKT effectively disrupts this immunosuppressive reprogramming, proposing targeted AKT blockade as a promising strategy to intercept the metastatic niche in CRC patients.

Supplementary files

Transparent peer review

To support increased transparency, we offer authors the option to publish the peer review history alongside their article.

View this article’s peer review history

Article information

Article type
Research Article
Submitted
09 Oct 2025
Accepted
06 Dec 2025
First published
20 Dec 2025

RSC Med. Chem., 2026, Accepted Manuscript

Kupffer cell M2-like polarization increases liver metastatic burden via uptake of exosomal KRAS mutant protein from hypoxic colorectal carcinoma cells

Y. You, Z. Feng, J. Lu, J. Xu, K. You, F. Liu, T. Wu, H. Song and Z. Liu, RSC Med. Chem., 2026, Accepted Manuscript , DOI: 10.1039/D5MD00897B

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements